Related Experiment Video
Updated: May 6, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
What is the best strategy for reducing deaths from heart disease?
Michael E Makover1, Shah Ebrahim
1New York University School of Medicine, New York, New York, USA. mmakover@optonline.net
Insights
Two strategies combat coronary artery disease: targeting high-risk individuals or improving population-wide risk factors. Both aim to reduce global deaths from heart disease.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Epidemiology
Background:
- Coronary artery disease (CAD) represents a significant global mortality burden.
- Two primary strategies exist for CAD prevention: the "high risk" approach and the "population" approach.
- The "high risk" strategy focuses on identifying and aggressively treating individuals with elevated risk factors, while the "population" strategy aims for broad shifts in risk factor distribution.
Purpose of the Study:
- To debate the merits and methodologies of the "high risk" versus the "population" approach for coronary artery disease prevention.
- To analyze the effectiveness of risk factor scoring and carotid ultrasound in identifying high-risk individuals.
- To evaluate the potential of population-wide interventions in reducing the overall incidence of heart disease.
Main Methods:
- Review of existing literature and epidemiological data on coronary artery disease.
- Analysis of risk assessment tools, including risk factor scoring and carotid ultrasound.
- Examination of public health strategies for modifying population-level risk factors for heart disease.
Main Results:
- The "high risk" approach enables targeted, intensive interventions for those most likely to develop cardiovascular events.
- The "population" approach seeks to reduce the average risk across all individuals, potentially preventing a larger number of events.
- The optimal strategy likely involves a combination of both approaches, tailored to specific contexts and populations.
Conclusions:
- Both the "high risk" and "population" strategies offer distinct pathways to reduce coronary artery disease mortality.
- Effective CAD prevention requires a comprehensive understanding of risk factor distribution and intervention efficacy.
- Further research is needed to optimize the integration of these strategies for maximum public health impact.
Background To The Debate:
Coronary artery disease is a major cause of death worldwide. Two very different approaches have been proposed as a way of reducing these deaths. The "high risk" approach uses tools such as risk factor scoring and carotid ultrasound to try and identify those at highest risk, and then treats them aggressively. The "population" approach aims to shift the distribution of risk factors across a population in a beneficial direction with the goal of reducing heart disease in the whole population.
More Related Videos
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management
Atherosclerosis III: Management